EA200970465A1 - Укороченные пептиды pth циклической конформации - Google Patents
Укороченные пептиды pth циклической конформацииInfo
- Publication number
- EA200970465A1 EA200970465A1 EA200970465A EA200970465A EA200970465A1 EA 200970465 A1 EA200970465 A1 EA 200970465A1 EA 200970465 A EA200970465 A EA 200970465A EA 200970465 A EA200970465 A EA 200970465A EA 200970465 A1 EA200970465 A1 EA 200970465A1
- Authority
- EA
- Eurasian Patent Office
- Prior art keywords
- pth
- cutted
- pth peptides
- cyclic conformation
- peptides
- Prior art date
Links
- 108090000445 Parathyroid hormone Proteins 0.000 abstract 4
- 102100036893 Parathyroid hormone Human genes 0.000 abstract 3
- 102000003982 Parathyroid hormone Human genes 0.000 abstract 1
- 230000004071 biological effect Effects 0.000 abstract 1
- 239000012634 fragment Substances 0.000 abstract 1
- 239000000199 parathyroid hormone Substances 0.000 abstract 1
- OGBMKVWORPGQRR-UMXFMPSGSA-N teriparatide Chemical compound C([C@H](NC(=O)[C@H](CCSC)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CCC(N)=O)NC(=O)[C@@H](NC(=O)[C@H](CCC(O)=O)NC(=O)[C@H](CO)NC(=O)[C@@H](NC(=O)[C@@H](N)CO)C(C)C)[C@@H](C)CC)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CC(C)C)C(=O)NCC(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC=1N=CNC=1)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CO)C(=O)N[C@@H](CCSC)C(=O)N[C@@H](CCC(O)=O)C(=O)N[C@@H](CCCNC(N)=N)C(=O)N[C@@H](C(C)C)C(=O)N[C@@H](CCC(O)=O)C(=O)N[C@@H](CC=1C2=CC=CC=C2NC=1)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCNC(N)=N)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H](CC(O)=O)C(=O)N[C@@H](C(C)C)C(=O)N[C@@H](CC=1N=CNC=1)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CC=1C=CC=CC=1)C(O)=O)C1=CNC=N1 OGBMKVWORPGQRR-UMXFMPSGSA-N 0.000 abstract 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- C07K14/575—Hormones
- C07K14/635—Parathyroid hormone, i.e. parathormone; Parathyroid hormone-related peptides
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- A61K38/22—Hormones
- A61K38/29—Parathyroid hormone, i.e. parathormone; Parathyroid hormone-related peptides
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/04—Drugs for disorders of the alimentary tract or the digestive system for ulcers, gastritis or reflux esophagitis, e.g. antacids, inhibitors of acid secretion, mucosal protectants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/14—Prodigestives, e.g. acids, enzymes, appetite stimulants, antidyspeptics, tonics, antiflatulents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P19/00—Drugs for skeletal disorders
- A61P19/02—Drugs for skeletal disorders for joint disorders, e.g. arthritis, arthrosis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P19/00—Drugs for skeletal disorders
- A61P19/08—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P19/00—Drugs for skeletal disorders
- A61P19/08—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease
- A61P19/10—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease for osteoporosis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
- A61P35/02—Antineoplastic agents specific for leukemia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Organic Chemistry (AREA)
- General Health & Medical Sciences (AREA)
- Medicinal Chemistry (AREA)
- Veterinary Medicine (AREA)
- Pharmacology & Pharmacy (AREA)
- Animal Behavior & Ethology (AREA)
- Public Health (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Endocrinology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Engineering & Computer Science (AREA)
- Physical Education & Sports Medicine (AREA)
- Rheumatology (AREA)
- Orthopedic Medicine & Surgery (AREA)
- Zoology (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Gastroenterology & Hepatology (AREA)
- Biochemistry (AREA)
- Biophysics (AREA)
- Toxicology (AREA)
- Molecular Biology (AREA)
- Genetics & Genomics (AREA)
- Immunology (AREA)
- Oncology (AREA)
- Hematology (AREA)
- Pulmonology (AREA)
- Pain & Pain Management (AREA)
- Nutrition Science (AREA)
- Epidemiology (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Peptides Or Proteins (AREA)
Abstract
Согласно настоящему изобретению предложены пептиды РТН, представляющие собой циклизованные содержащие замены аналоги РТН(1-17), укороченного фрагмента РТН, которые предпочтительно сохраняет желаемую или близкую биологическую активность РТН (1-34) человека.
Applications Claiming Priority (3)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US87372306P | 2006-12-08 | 2006-12-08 | |
EP06025423A EP1961765A1 (en) | 2006-12-08 | 2006-12-08 | Truncated PTH peptides with a cyclic conformation |
PCT/GB2007/004664 WO2008068487A1 (en) | 2006-12-08 | 2007-12-06 | Truncated pth peptides with a cyclic conformation |
Publications (1)
Publication Number | Publication Date |
---|---|
EA200970465A1 true EA200970465A1 (ru) | 2010-02-26 |
Family
ID=38230002
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
EA200970465A EA200970465A1 (ru) | 2006-12-08 | 2007-12-06 | Укороченные пептиды pth циклической конформации |
Country Status (12)
Country | Link |
---|---|
US (1) | US20100048462A1 (ru) |
EP (2) | EP1961765A1 (ru) |
JP (1) | JP2010511686A (ru) |
KR (1) | KR20090096506A (ru) |
CN (1) | CN101600735A (ru) |
AU (1) | AU2007330617B2 (ru) |
BR (1) | BRPI0719874A2 (ru) |
CA (1) | CA2670950A1 (ru) |
EA (1) | EA200970465A1 (ru) |
MX (1) | MX2009005788A (ru) |
NZ (1) | NZ578227A (ru) |
WO (1) | WO2008068487A1 (ru) |
Families Citing this family (14)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
EP2187902B1 (en) | 2007-08-01 | 2013-04-17 | The General Hospital Corporation | Screening methods using g-protein coupled receptors and related compositions |
EP2411038B1 (en) | 2009-03-27 | 2016-12-28 | Van Andel Research Institute | Parathyroid hormone peptides and parathyroid hormone-related protein peptides and methods of use |
WO2010128521A2 (en) | 2009-04-24 | 2010-11-11 | Cadila Healthcare Limited | Short-chain peptides as parathyroid hormone (pth) receptor agonist |
PL3133070T3 (pl) * | 2009-11-27 | 2020-01-31 | Genzyme Corporation | Eliglustat (Genz 112638) jako inhibitor syntazy glukozyloceramidowej do zastosowania w sposobie leczenia choroby Fabry’ego lub choroby Gauchera, przy czym sposób obejmuje dostosowanie indywidualnej dawki terapeutycznej do metabolizmu P450 u pacjenta |
RU2604809C2 (ru) * | 2010-05-13 | 2016-12-10 | Дзе Дженерал Хоспитал Корпорейшн | Аналоги паратиреоидного гормона и их применение |
US20120184494A1 (en) * | 2010-11-12 | 2012-07-19 | Maurizio Zangari | Multiple myeloma prognosis and treatment |
WO2012120532A2 (en) | 2011-02-02 | 2012-09-13 | Cadila Healthcare Limited | Cyclic short chain peptides |
WO2012158962A2 (en) * | 2011-05-18 | 2012-11-22 | Eumederis Pharmaceuticals, Inc. | Improved peptide pharmaceuticals |
ES2816009T3 (es) * | 2011-12-14 | 2021-03-31 | Univ Arkansas | Administración de agentes terapéuticos mediante una proteína de unión a colágeno |
EP3434696A1 (en) | 2012-11-20 | 2019-01-30 | Mederis Diabetes, LLC | Improved peptide pharmaceuticals for insulin resistance |
CN117180445A (zh) | 2014-05-28 | 2023-12-08 | 梅德瑞斯糖尿病有限责任公司 | 针对胰岛素抵抗的改良肽药物 |
PL3464336T3 (pl) | 2016-06-01 | 2022-05-16 | Athira Pharma, Inc. | Związki |
IL311775A (en) | 2018-01-03 | 2024-05-01 | Mederis Diabetes Llc | Improved peptide drugs for the treatment of NASH and other disorders |
EP3796941A4 (en) * | 2018-05-30 | 2022-12-28 | Purdue Research Foundation | TARGETING ANABOLIC DRUGS FOR ACCELERATED FRACTURE REPAIR |
Family Cites Families (39)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US4659696A (en) * | 1982-04-30 | 1987-04-21 | Takeda Chemical Industries, Ltd. | Pharmaceutical composition and its nasal or vaginal use |
US5527772A (en) * | 1987-10-20 | 1996-06-18 | Holick; Michael F. | Regulation of cell proliferation and differentiation using peptides |
US5624898A (en) * | 1989-12-05 | 1997-04-29 | Ramsey Foundation | Method for administering neurologic agents to the brain |
JP3090353B2 (ja) * | 1991-09-17 | 2000-09-18 | 旭化成工業株式会社 | パラチロイドホルモン類含有経鼻投与用乳剤 |
US5563122A (en) * | 1991-12-09 | 1996-10-08 | Asahi Kasei Kogyo Kabushiki Kaisha | Stabilized parathyroid hormone composition |
US5977070A (en) * | 1992-07-14 | 1999-11-02 | Piazza; Christin Teresa | Pharmaceutical compositions for the nasal delivery of compounds useful for the treatment of osteoporosis |
CA2145418A1 (en) * | 1992-09-29 | 1994-04-14 | John S. Patton | Pulmonary delivery of active fragments of parathyroid hormone |
US5496801A (en) * | 1993-12-23 | 1996-03-05 | Allelix Biopharmaceuticals Inc. | Parathyroid hormone formulation |
US5747456A (en) * | 1994-12-19 | 1998-05-05 | Beth Israel Deaconess Medical Center | Continuous low-dose administration of parathyroid hormone or its agonist |
US5717062A (en) * | 1995-06-07 | 1998-02-10 | Beth Israel Hospital Association | Cyclic analogs of PTH and PTHrP |
US5723577A (en) * | 1995-07-13 | 1998-03-03 | Biomeasure Inc. | Analogs of parathyroid hormone |
ATE219374T1 (de) * | 1996-02-01 | 2002-07-15 | Chugai Pharmaceutical Co Ltd | Medikamente für die behandlung oder vorbeugung von thrombocytopenie |
DE69734157T2 (de) * | 1996-07-31 | 2006-07-13 | The General Hospital Corp., Boston | Parathyroidhormon-verwandthe peptidanaloge |
US6183974B1 (en) * | 1997-07-31 | 2001-02-06 | The General Hospital Corporation | Screening assays for G protein coupled receptor agonists and antagonists |
EP1005359B1 (en) * | 1997-09-09 | 2005-06-15 | F. Hoffmann-La Roche Ag | FRACTURE HEALING USING PTHrP ANALOGS |
US6770623B1 (en) * | 1997-12-09 | 2004-08-03 | Eli Lilly And Company | Stabilized teriparatide solutions |
IL138214A0 (en) * | 1998-03-09 | 2001-10-31 | Zealand Pharmaceuticals As | Pharmacolgically active peptide conjugates having a reduced tendency towards enzymatic hydrolysis |
AR033639A1 (es) * | 1998-08-19 | 2004-01-07 | Lilly Co Eli | Uso de hormonas paratiroideas para preparar medicamentos para reducir el riesgo de fracturas oseas vertebrales o no vertebrales en seres humanos con riesgo de padecer o que padecen osteoporosis |
EP1123401A1 (en) * | 1998-10-22 | 2001-08-16 | The General Hospital Corporation | BIOACTIVE PEPTIDES AND PEPTIDE DERIVATIVES OF PARATHYROID HORMONE (PTH) AND PARATHYROID HORMONE-RELATED PEPTIDE (PTHrP) |
JP4486258B2 (ja) * | 1998-11-25 | 2010-06-23 | ザ・ジェネラル・ホスピタル・コーポレイション | ヒト副甲状腺ホルモンの改変、調製および使用 |
DE69938064T2 (de) * | 1998-11-25 | 2009-01-15 | The General Hospital Corp., Boston | Aminoterminal modifizierte parathyroidhormon (pth) analoge |
AU4217299A (en) * | 1998-11-30 | 2000-06-19 | General Hospital Corporation, The | Pth1r and pth3r receptors, methods and uses thereof |
EP1141237B1 (en) * | 1998-12-31 | 2005-11-02 | The General Hospital Corporation | Pth receptor and screening assay utilizing the same |
US7057012B1 (en) * | 1998-12-31 | 2006-06-06 | The General Hospital Corporation | PTH functional domain conjugate peptides, derivatives thereof and novel tethered ligand-receptor molecules |
US6316410B1 (en) * | 1999-09-22 | 2001-11-13 | National Research Council Of Canada | Parathyroid hormone analogues for the treatment of osteoporosis |
US7022815B1 (en) * | 1999-09-29 | 2006-04-04 | The General Hospital Corporation | Polypeptide derivatives of parathyroid hormone (PTH) |
US7022674B2 (en) * | 1999-12-16 | 2006-04-04 | Eli Lilly And Company | Polypeptide compositions with improved stability |
US6340477B1 (en) * | 2000-04-27 | 2002-01-22 | Lifenet | Bone matrix composition and methods for making and using same |
CN100518819C (zh) * | 2000-06-30 | 2009-07-29 | 阿斯比奥制药株式会社 | 含有人甲状旁腺激素的药物成分及含有该成分的用于鼻内给药的药物组合物 |
CA2454275C (en) * | 2001-07-23 | 2012-10-23 | The General Hospital Corporation | Conformationally constrained parathyroid hormone (pth) analogs |
EP2295089B1 (en) * | 2002-07-31 | 2018-05-09 | DENTSPLY SIRONA Inc. | Bone repair putty comprising porous particulate and carrier gel |
AU2003217243A1 (en) * | 2003-01-24 | 2004-08-23 | Thomas J. Gardella | Conformationally constrained parathyroid hormone (pth) analogs with lactam bridges |
EP1610813A4 (en) * | 2003-03-19 | 2009-07-01 | Gen Hospital Corp | PARATHYROIDAL HORMONES CONFORMALLY CONFORMALLY CONSTRAINED WITH PROPELLER STABILIZERS $ G (A) |
WO2005007184A2 (en) * | 2003-07-15 | 2005-01-27 | National Research Council Of Canada | Cyclic analogs of human parathyroid hormone for the treatment of conditions characterized by hyperproliferative skin cells |
US7910544B2 (en) * | 2003-07-17 | 2011-03-22 | The General Hospital Corporation | Conformationally constrained parthyroid hormone (PTH) analogs |
EP1677846B1 (en) * | 2003-10-22 | 2014-08-20 | Encelle, Inc. | Bioactive hydrogel compositions for regenerating connective tissue |
US20050215476A1 (en) * | 2004-01-21 | 2005-09-29 | Unigene Laboratories Inc. | Amidated parathyroid hormone fragments and uses thereof |
RU2006143544A (ru) * | 2004-05-10 | 2008-06-20 | Нэстек Фармасьютикал Кампани Инк. (Us) | Композиции и способ для облегченной чресслизистой доставки паратиреоидного гормона |
EP2054077A4 (en) * | 2006-08-04 | 2010-10-13 | Gen Hospital Corp | POLYPEPTIDE DERIVATIVES OF PARATHYROID HORMONE (PTH) |
-
2006
- 2006-12-08 EP EP06025423A patent/EP1961765A1/en not_active Withdrawn
-
2007
- 2007-12-06 BR BRPI0719874-4A2A patent/BRPI0719874A2/pt not_active IP Right Cessation
- 2007-12-06 WO PCT/GB2007/004664 patent/WO2008068487A1/en active Application Filing
- 2007-12-06 CA CA002670950A patent/CA2670950A1/en not_active Abandoned
- 2007-12-06 MX MX2009005788A patent/MX2009005788A/es not_active Application Discontinuation
- 2007-12-06 KR KR1020097014094A patent/KR20090096506A/ko active Search and Examination
- 2007-12-06 EA EA200970465A patent/EA200970465A1/ru unknown
- 2007-12-06 CN CNA2007800510229A patent/CN101600735A/zh active Pending
- 2007-12-06 AU AU2007330617A patent/AU2007330617B2/en not_active Ceased
- 2007-12-06 JP JP2009539804A patent/JP2010511686A/ja active Pending
- 2007-12-06 NZ NZ578227A patent/NZ578227A/en not_active IP Right Cessation
- 2007-12-06 US US12/518,171 patent/US20100048462A1/en not_active Abandoned
- 2007-12-06 EP EP07858773A patent/EP2054438A1/en not_active Withdrawn
Also Published As
Publication number | Publication date |
---|---|
CA2670950A1 (en) | 2008-06-12 |
EP1961765A1 (en) | 2008-08-27 |
BRPI0719874A2 (pt) | 2014-04-15 |
CN101600735A (zh) | 2009-12-09 |
AU2007330617A1 (en) | 2008-06-12 |
AU2007330617B2 (en) | 2012-11-29 |
NZ578227A (en) | 2011-06-30 |
US20100048462A1 (en) | 2010-02-25 |
JP2010511686A (ja) | 2010-04-15 |
WO2008068487A1 (en) | 2008-06-12 |
MX2009005788A (es) | 2009-06-08 |
EP2054438A1 (en) | 2009-05-06 |
KR20090096506A (ko) | 2009-09-10 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
EA200970465A1 (ru) | Укороченные пептиды pth циклической конформации | |
NL301089I2 (nl) | imlifidase | |
EA201290557A1 (ru) | Пептидный аналог оксинтомодулина | |
EA200702529A1 (ru) | Фунгицидная комбинация биологически активных веществ | |
EA200971077A1 (ru) | Гетероциклические модуляторы киназы | |
CR9253A (es) | Fijacion de la dosificacion de anticuerpos her | |
EA201690526A1 (ru) | Замещенные нуклеозиды, нуклеотиды и их аналоги | |
BRPI0808775A2 (pt) | compostos e composições como moduladores de atividade de gpr119 | |
NO20082753L (no) | Transdermalt terapeutisk system | |
HN2005000477A (es) | Compuestos de aminoheteroarilo sustituidos con piraol como inhibidores de proteina quinasa | |
ECSP077360A (es) | Compuestos sulfonamida | |
ECSP067121A (es) | 3-aminociclopentanocarboxamidas como moduladores de receptores de quimioquinas | |
ATE478863T1 (de) | Heterotetracyclische verbindungen als tpo- mimetica | |
CR9223A (es) | 18-metil-19-nor-17-pregn-4-en-21, 17-carbolactonas,asi como preparaciones farmaceuticas que las contienen | |
CY1113024T1 (el) | Σπειροκυκλικα παραγωγα κυκλοεξανιου για τη θεραπεια της εξαρτησης ουσιων | |
CY1111212T1 (el) | Θειικες ενωσεις ως αναστολεις της πρωτεασης σερινης ns3 του ιου της ηπατιτιδας γ | |
EA201270423A1 (ru) | Ингибиторы протеазы hcv | |
BRPI0605926A2 (pt) | ciclopentanos substituìdos ou ciclopentanonas como agentes terapêuticos | |
DE602006013907D1 (de) | Sicherheitsschildsystem für medizinische Nadeln | |
EA200702193A1 (ru) | Гликозилирование белков | |
BR112012008004A2 (pt) | compostos e composições como moduladores da atividade de gpr119 | |
CR10060A (es) | 3-aminociclopentanocarboxamidas como moduladores de receptores de quimioquinas | |
EA200801180A1 (ru) | Селективные пептидные агонисты рецептора vpac2 | |
EA200900261A1 (ru) | Применение эсцина | |
ATE417849T1 (de) | Pyrazoloä4,3-düpyrimidine |